Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dragica Udiljak"'
Autor:
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, Gerulf Hänel, Nora Philipp, Florian Märkl, Thaddäus Strzalkowski, Sonja M. Lacher, Dragica Udiljak, Karsten Spiekermann, Sebastian Theurich, Sebastian Kobold, Roman Kischel, John R. James, Veit L. Bücklein, Marion Subklewe
Publikováno v:
Cancer Immunology, Immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44e89147d3fb33bc7a716fe89d6309ea
https://doi.org/10.1007/s00262-023-03457-9
https://doi.org/10.1007/s00262-023-03457-9
Autor:
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, Gerulf Hänel, Nora Philipp, Florian Märkl, Thaddäus Strzalkowski, Sonja M. Lacher, Dragica Udiljak, Karsten Spiekermann, Sebastian Theurich, Sebastian Kobold, Roman Kischel, John R. James, Veit L. Bücklein, Marion Subklewe
Publikováno v:
Cancer Immunology, Immunotherapy.
Bispecific T-cell engager (BiTE®) molecules recruit T cells to cancer cells through CD3ε binding, independently of T-cell receptor (TCR) specificity. Whereas physiological T-cell activation is dependent on signal 1 (TCR engagement) and signal 2 (co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d261a13bce3e2164141a44c5580a8a48
https://doi.org/10.1007/s00262-023-03439-x
https://doi.org/10.1007/s00262-023-03439-x
Autor:
Michael von Bergwelt, Bettina Brauchle, Marion Subklewe, Felix S. Lichtenegger, Dragica Udiljak, Anetta Marcinek, Peter Kufer, Roman Kischel, Karsten Spiekermann
Publikováno v:
Blood. 132:1349-1349
Bispecific T-cell engagers (BiTE® antibody constructs) represent a novel immunotherapeutic strategy relying on the recruitment of T cells against tumor cells independent of TCR specificity. In Acute Myeloid Leukemia (AML), CD33 represents a suitable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b40c954dee9c905df0c0bb1df028d0ca
https://doi.org/10.1182/blood-2018-99-116297
https://doi.org/10.1182/blood-2018-99-116297